Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XASEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.53EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.57EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.8.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CA.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ED.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BU.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCGEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DT.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCAEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.50EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GN.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.77 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.93 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.31.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BW.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.312EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.13.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.220EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used